Telecom giant Verizon Communications (NYSE: VZ) reported a decline in second-quarter revenues, reflecting the disruption caused by the pandemic. Consequently, earnings decreased 4% annually but came in above the market’s forecast.
Operating revenues dropped 5.1% annually to $30.4 billion, which was slightly above the consensus estimate. Adjusted earnings declined to $1.18 per share from $1.23 per share in the second quarter of 2020. Unadjusted profit was $1.13 per share, up from $0.95 per share recorded a year earlier.
Verizon’s stock made modest gains early Friday following the announcement. It had closed the last trading session slightly higher.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment